OcyonBio Seeks FDA ‘Gold Star’ For Puerto Rico Biosimilar Manufacturing
Recent Deal Signed With Reliance Life Sciences JV Biosimilar Solutions
In the wake of signing a drug transfer and development agreement with Biosimilar Solutions in the firms’ native Puerto Rico, OcyonBio’s CEO Robert Salcedo spoke with Generics Bulletin about the company’s ambitions to put the US territory on the map for biosimilars.
You may also be interested in...
The AMR Industry Alliance has formalized its years-old Common Antibiotic Manufacturing Framework by publishing an antibiotic manufacturing standard, in what it terms a “groundbreaking step” in the drive for responsible manufacturing.
Cigna has responded to several questions from the insurer/payer side on the potential effect of multiple biosimilar Humira products launching in 2023 and beyond.
China’s HEC Pharm, the last ANDA filer for fingolimod standing in patent litigation, has won a key invalidity challenge against a dosing-regimen patent shielding the multiple sclerosis treatment. However, the Federal Circuit was split on whether it had applied a heightened standard for negative claim limitations.